Luo D, Long Y, Liu L, Chen X, Guo Y
SAGE Open Med Case Rep. 2024; 12:2050313X241305905.
PMID: 39669799
PMC: 11635891.
DOI: 10.1177/2050313X241305905.
Lv Q, Niu Y, Xu Z, Qin J, Yang Z
Front Neurol. 2024; 15:1410187.
PMID: 39416667
PMC: 11482035.
DOI: 10.3389/fneur.2024.1410187.
Tin W, Xiao C, Sun K, Zhao Y, Xie M, Zheng J
Front Oncol. 2024; 14:1427776.
PMID: 39224802
PMC: 11366590.
DOI: 10.3389/fonc.2024.1427776.
Yu C, Wang J, Li Y
Biochem Genet. 2024; .
PMID: 38918306
DOI: 10.1007/s10528-024-10865-8.
Peng Y, Qian H, Xu W, Xiao M, Ding C, Liu F
Cell Death Dis. 2024; 15(6):416.
PMID: 38879600
PMC: 11180176.
DOI: 10.1038/s41419-024-06819-y.
De novo truncating variants of TRIM8 and atypical neuro-renal syndrome: a case report and literature review.
Li W, Guo H
Ital J Pediatr. 2023; 49(1):46.
PMID: 37061734
PMC: 10105407.
DOI: 10.1186/s13052-023-01453-4.
TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt.
Hosseinalizadeh H, Mohamadzadeh O, Kahrizi M, Razaghi Bahabadi Z, Klionsky D, Mirzei H
Cell Mol Biol Lett. 2023; 28(1):6.
PMID: 36690946
PMC: 9869596.
DOI: 10.1186/s11658-023-00418-z.
TRIM31: A molecule with a dual role in cancer.
Guo Y, Lin P, Hua Y, Wang C
Front Oncol. 2023; 12:1047177.
PMID: 36620540
PMC: 9815508.
DOI: 10.3389/fonc.2022.1047177.
Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications.
Gao Y, Pan T, Xu G, Li S, Guo J, Zhang Y
Hum Genomics. 2022; 16(1):65.
PMID: 36461099
PMC: 9719184.
DOI: 10.1186/s40246-022-00441-9.
Whole-transcriptome sequencing identifies neuroinflammation, metabolism and blood-brain barrier related processes in the hippocampus of aged mice during perioperative period.
Suo Z, Yang J, Zhou B, Qu Y, Xu W, Li M
CNS Neurosci Ther. 2022; 28(10):1576-1595.
PMID: 35899365
PMC: 9437242.
DOI: 10.1111/cns.13901.
Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis.
Esposito J, De Iuliis V, Avolio F, Liberatoscioli E, Pulcini R, Di Francesco S
Cancers (Basel). 2022; 14(9).
PMID: 35565438
PMC: 9099786.
DOI: 10.3390/cancers14092309.
A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
Zheng D, Zhang Y, Xia Y, Cheng F
Front Oncol. 2022; 12:840410.
PMID: 35371994
PMC: 8968921.
DOI: 10.3389/fonc.2022.840410.
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma.
Liu D, Hu Z, Jiang J, Zhang J, Hu C, Huang J
Sci Rep. 2022; 12(1):1617.
PMID: 35102149
PMC: 8804019.
DOI: 10.1038/s41598-022-05103-3.
The Emerging Roles of Tripartite Motif Proteins (TRIMs) in Acute Lung Injury.
Huang Y, Xiao Y, Zhang X, Huang X, Li Y
J Immunol Res. 2021; 2021:1007126.
PMID: 34712740
PMC: 8548118.
DOI: 10.1155/2021/1007126.
Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
Nastase A, Mandal A, Lu S, Anbunathan H, Morris-Rosendahl D, Zhi Zhang Y
Sci Rep. 2021; 11(1):19138.
PMID: 34580349
PMC: 8476593.
DOI: 10.1038/s41598-021-98414-w.
Ubiquitination, Biotech Startups, and the Future of TRIM Family Proteins: A TRIM-Endous Opportunity.
Bhaduri U, Merla G
Cells. 2021; 10(5).
PMID: 33923045
PMC: 8146955.
DOI: 10.3390/cells10051015.
TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance.
Marzano F, Caratozzolo M, Pesole G, Sbisa E, Tullo A
Biomedicines. 2021; 9(3).
PMID: 33673719
PMC: 7997459.
DOI: 10.3390/biomedicines9030241.
Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class.
DAmico F, Mukhopadhyay R, Ovaa H, Mulder M
Chembiochem. 2021; 22(12):2011-2031.
PMID: 33482040
PMC: 8251876.
DOI: 10.1002/cbic.202000787.